JPRN-C000000439未知1 期
Phase 1/2 study of the combination of gemcitabine and nedaplation for treatment of previously untreated advanced squamous cell lung cancer - Phase1/2 study of gemcitabine and nedaplation for treatment of previously untreated advanced squamous cell lung cancer
Department of Respiratory Medicine of Kyoto University Hospital0 个研究点目标入组 32 人开始时间: 2006年7月1日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 发起方
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Interstitial pneumonia or pulmonary fibrosis on chest X-P 2) peural or pericardial effusion requiring drainage 3) SVC syndrome 4) Symptomatic brain metastases 5) Active concominant malignancies 6) Uncontrolled diabetes mellitus or hypertension 7) Liver cirrhosis 8) Severe cardiovascular diseases 9) Pregnancy and lactation 10) Ccr<60ml/min 11) A history of serious drug allergy 12) Acute infection 13) Bleeding tendency 14) Unsuitable for entry to the study, decided by a medical oncologist
研究者
相似试验
已完成
不适用
Phase 2 study of the combination of gemcitabine and nedaplation for treatment of previously untreated advanced squamous cell lung cancerung squamous cell carcinomaJPRN-UMIN000004833First Department of Surgery, Hamamatsu University School of Medicine25
已完成
不适用
A combination phase I/II study of gemcitabine with carboplatin for previously untreated elderly non-small cell lung cancerpreviously untreated elderly non-small cell lung cancerJPRN-C000000072West Japan Oncology Group25
已完成
2 期
Phase II trial of the combination of gemcitabine and 131I-MIBG therapy in paediatric patients with relapsed or progressive neuroblastomaNL-OMON39557Academisch Medisch Centrum16
进行中（未招募）
不适用
A phase II study of the combination of gemcitabine with 131I-MIBG therapy for children with neuroblastoma without other treatment options.relapsed or progressive neuroblastoma in pediatric patients of 1 to 18 yearsEUCTR2007-007974-45-NLAMC47
已完成
2 期
A combination phase II study of gemcitabine with carboplatin for previously untreated elderly non-small cell lung cancer.on-small cell lung cancerJPRN-C000000135Institute of Biomedical Research and Innovation40